Eukaryotic elongation factor 2 kinase controls proliferation and migration of vascular smooth muscle cells

Acta Physiologica

Volumn 213, Issue 2, 2015, Pages 472-480

  Usui, T ^a   Nijima, R ^a   Sakatsume, T ^a   Otani, K ^a   Kameshima, S ^a   Okada, M ^a   Yamawaki, H ^a  

^a KITASATO UNIVERSITY   (Japan)

Author keywords

Growth factors; Hypertension; Signal transduction; Vascular smooth muscle

Indexed keywords

A 484954; ELONGATION FACTOR 2 KINASE; EUKARYOTIC ELONGATION FACTOR 2 KINASE; HEAT SHOCK PROTEIN 27; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PLATELET DERIVED GROWTH FACTOR BB; PROTEIN KINASE B; PROTEIN SERINE THREONINE KINASE INHIBITOR; UNCLASSIFIED DRUG; EEF2K PROTEIN, MOUSE; HSPB1 PROTEIN, HUMAN; PLATELET DERIVED GROWTH FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; HYPERTENSION; MALE; MESENTERIC ARTERY; NONHUMAN; PATHOGENESIS; PHASE CONTRAST MICROSCOPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SMOOTH MUSCLE FIBER; SPONTANEOUSLY HYPERTENSIVE RAT; VASCULAR SMOOTH MUSCLE; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL CULTURE; CELL MOTION; DRUG EFFECTS; METABOLISM; PHYSIOLOGY; WISTAR RAT;

ANIMALS; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; ELONGATION FACTOR 2 KINASE; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HSP27 HEAT-SHOCK PROTEINS; HYPERTENSION; MALE; MITOGEN-ACTIVATED PROTEIN KINASES; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PLATELET-DERIVED GROWTH FACTOR; RATS, WISTAR;

EID: 84920927328     PISSN: 17481708     EISSN: 17481716     Source Type: Journal    
DOI: 10.1111/apha.12354     Document Type: Article

References (28)

1. Calberg, U., Nilsson, A., Skog, S., Palmquist, K. & Nygård, O. 1991. Increased activity of the eEF-2 specific, Ca2+ and calmodulin dependent protein kinase III during the S-phase in Ehrlich ascites cells. Biochem Biophys Res Commun 180, 1372-1376.
2. Chen, Z., Gopalakrishnan, S.M., Bui, M.H., Soni, N.B., Warrior, U., Johnson, E.F., Donnelly, J.B. & Glaser, K.B. 2011. 1-Benzyl-3-cetyl-2-methylimidazolium iodide (NH125) induces phosphorylation of eukaryotic elongation factor-2 (eEF2): a cautionary note on the anticancer mechanism of an eEF2 kinase inhibitor. J Biol Chem 286, 43951-43958.
3. Cheng, E.H., Gorelick, F.S., Czernik, A.J., Bagaglio, D.M. & Hait, W.N. 1995. Calmodulin-dependent protein kinases in rat glioblastoma. Cell Growth Differ 6, 615-621.
4. Coen, M., Marchetti, G., Palagi, P. M., Zerbinati, C., Guastella, G., Gagliano, T., Bernardi, F., Mascoli, F. & Bochaton-Piallat, M. L. 2013. Calmodulin expression distinguishes the smooth muscle cell population of human carotid plaque. Am J Pathol 183, 996-1009.
5. Egan, C.G., Wainwright, C.L., Wadsworth, R.M. & Nixon, G.F. 2005. PDGF-induced signaling in proliferating and differentiated vascular smooth muscle: effects of altered intracellular Ca2+ regulation. Cardiovasc Res 67, 308-316.
6. Farrer, R.G., Farrer, J.R. & DeVries, G.H. 2013. Platelet-derived growth factor-BB activates calcium/calmodulin-dependent and -independent mechanisms that mediate Akt phosphorylation in the neurofibromin-deficient human Schwann cell line ST88-14. J Biol Chem 288, 11066-11073.
7. Hait, W.N., Wu, H., Jin, S. & Yang, J.M. 2006. Elongation factor-2 kinase: its role in protein synthesis and autophagy. Autophagy 2, 294-296.
8. Hizli, A.A., Chi, Y., Swanger, J., Carter, J.H., Liao, Y., Welcker, M., Ryazanov, A.G. & Clurman, B.E. 2013. Phosphorylation of eukaryotic elongation factor 2 (eEF2) by cyclin A-cyclin-dependent kinase 2 regulates its inhibition by eEF2 kinase. Mol Cell Biol 33, 596-604.
9. Kazama, K., Usui, T., Okada, M., Hara, Y. & Yamawaki, H. 2012. Omentin plays an anti-inflammatory role through inhibition of TNF-alpha-induced superoxide production in vascular smooth muscle cells. Eur J Pharmacol 686, 116-123.
10. Kazama, K., Okada, M. & Yamawaki, H. 2014. A novel adipocytokine, omentin, inhibits platelet-derived growth factor-BB-induced vascular smooth muscle cell migration through antioxidative mechanism. Am J Physiol Heart Circ Physiol 306, H1714-H1719.
11. Nairn, A.C. & Palfrey, H.C. 1987. Identification of the major Mr 100, 000 substrate for calmodulin-dependent protein kinase III in mammalian cells as elongation factor-2. J Biol Chem 262, 17299-17303.
12. Okada, M., Suzuki, A., Yamawaki, H. & Hara, Y. 2013. Levosimendan inhibits interleukin-1beta-induced cell migration and MMP-9 secretion in rat cardiac fibroblasts. Eur J Pharmacol 718, 332-339.
13. Phalitakul, S., Okada, M., Hara, Y. & Yamawaki, H. 2012. A novel adipocytokine, vaspin inhibits platelet-derived growth factor-BB-induced migration of vascular smooth muscle cells. Biochem Biophys Res Commun 423, 844-849.
14. Pigott, C.R., Mikolajek, H., Moore, C.E., Finn, S.J., Phippen, C.W., Werner, J.M. & Proud, C.G. 2012. Insights into the regulation of eukaryotic elongation factor 2 kinase and the interplay between its domains. Biochem J 442, 105-118.
15. Price, N.T., Redpath, N.T., Severinov, K.V., Campbell, D.G., Russell, J.M. & Proud, C.G. 1991. Identification of the phosphorylation sites in elongation factor-2 from rabbit reticulocytes. FEBS Lett 282, 253-258.
16. Pyr Dit Ruys, S., Wang, X., Smith, E. M., Herinckx, G., Hussain, N., Rider, M. H., Vertommen, D. & Proud, C. G. 2012. Identification of autophosphorylation sites in eukaryotic elongation factor-2 kinase. Biochem J 442, 681-692.
17. Rhee, S.G. 2001. Regulation of phosphoinositide-specific phospholipase C. Annu Rev Biochem 70, 281-312.
18. Ryazanov, A.G. & Davydova, E.K. 1989. Mechanism of elongation factor 2 (EF-2) inactivation upon phosphorylation. Phosphorylated EF-2 is unable to catalyze translocation. FEBS Lett 251, 187-190.
19. Ryazanov, A.G., Ward, M.D., Mendola, C.E., Pavur, K.S., Dorovkov, M.V., Wiedmann, M., Erdjument-Bromage, H., Tempst, P., Parmer, T.G., Prostko, C.R., Germino, F.J. & Hait, W.N. 1997. Identification of a new class of protein kinases represented by eukaryotic elongation factor-2 kinase. Proc Natl Acad Sci USA 94, 4884-4889.
20. Smith, E.M. & Proud, C.G. 2008. cdc2-cyclin B regulates eEF2 kinase activity in a cell cycle- and amino acid-dependent manner. EMBO J 27, 1005-1016.
21. Tada, T., Nawata, J., Wang, H., Onoue, N., Zhulanqiqige, D., Ito, K., Sugimura, K., Fukumoto, Y. & Shimokawa, H. 2008. Enhanced pulsatile pressure accelerates vascular smooth muscle migration: implications for atherogenesis of hypertension. Cardiovasc Res 80, 346-353.
22. Usui, T., Okada, M., Hara, Y. & Yamawaki, H. 2011. Exploring calmodulin-related proteins, which mediate development of hypertension, in vascular tissues of spontaneous hypertensive rats. Biochem Biophys Res Commun 405, 47-51.
23. Usui, T., Okada, M., Hara, Y. & Yamawaki, H. 2012a. Death-associated protein kinase 3 mediates vascular inflammation and development of hypertension in spontaneously hypertensive rats. Hypertension 60, 1031-1039.
24. Usui, T., Okada, M., Mizuno, W., Oda, M., Ide, N., Morita, T., Hara, Y. & Yamawaki, H. 2012b. HDAC4 mediates development of hypertension via vascular inflammation in spontaneous hypertensive rats. Am J Physiol Heart Circ Physiol 302, H1894-H1904.
25. Usui, T., Okada, M., Hara, Y. & Yamawaki, H. 2013. Eukaryotic elongation factor 2 kinase regulates the development of hypertension through oxidative stress-dependent vascular inflammation. Am J Physiol Heart Circ Physiol 305, H756-H768.
26. Usui, T., Moriota, T., Okada, M. & Yamawaki, H. 2014. Histone diacetylase 4 controls neointimal hyperplasia via stimulating proliferation and migration of vascular smooth muscle cells. Hypertension 63, 397-403.
27. Wu, H., Yang, J.M., Jin, S., Zhang, H. & Hait, W.N. 2006. Elongation factor-2 kinase regulates autophagy in human glioblastoma cells. Cancer Res 66, 3015-3023.
28. Zhang, H., Bialkowska, A., Rusovici, R., Chanchevalap, S., Shim, H., Katz, J.P., Yang, V.W. & Yun, C.C. 2007. Lysophosphatidic acid facilitates proliferation of colon cancer cells via induction of Kruppel-like factor 5. J Biol Chem 282, 15541-15549.